AstraZeneca has cut operational emissions 77.5% since 2015 and locked in science-based net-zero targets, but absolute supply chain emissions are rising 18.6% from baseline. Operations excel; supply chain and delivery risk on Scope 3 are the dominant weaknesses. Trade association memberships undermine climate advocacy clarity.
Same formula for every company. No curve. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × ScaleStrongest on Carbon Footprint — Operations and Energy Source (9/10, 9/10). Weakest on Emissions Trajectory and Resource Use & Waste (4/10, 6/10).
12 sources used in this assessment. All publicly available. Each row shows which rubric questions it informed.
If you believe a source has been misread or a newer version exists, submit a challenge.
Among the 11 major healthcare / pharmaceuticals brands we've scored, AstraZeneca sits 1st of 11.
Score history begins 4 April 2026.
As AstraZeneca's score updates, the trajectory will appear here.
We're backfilling historical scores for FTSE 100 and S&P 100 companies over the coming weeks.
Every challenge is published. We'd rather be corrected than wrong — that's the whole point.
No challenges submitted yet. If you have evidence that contradicts this score, you can challenge any question above — cite a public source and we'll review it.
AstraZeneca is a British-Swedish pharmaceutical company headquartered in Cambridge, UK, founded in 1913. With 70,600 employees and $24.4B FY2019 revenue, it ranks among the world's largest research-driven drugmakers, operating across oncology, cardiovascular, and respiratory therapy segments.
Peer pharma with similar SBTi net-zero targets and Scope 3 supply chain complexity
View breakdown →Comparable pharmaceutical scale; broader nature-positive and water stewardship programmes
View breakdown →Swiss-listed pharma with aggressive renewable energy and API pollution control initiatives
View breakdown →Renewable energy partner model; demonstrates credible net-zero transition pathway execution
View breakdown →Email alerts when a rubric question is verified, a challenge is resolved, or the overall score changes.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Readers and institutions support our work. Companies can pay to submit evidence we couldn't find. Neither type of payment changes a score.